6p2u
From Proteopedia
(Difference between revisions)
m (Protected "6p2u" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Structure of Mortalin-NBD with N6-propargyladenosine-5'-diphosphate== | |
+ | <StructureSection load='6p2u' size='340' side='right'caption='[[6p2u]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[6p2u]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6P2U OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6P2U FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NO7:9-{5-O-[(S)-hydroxy(phosphonooxy)phosphoryl]-alpha-D-ribofuranosyl}-N-(prop-2-yn-1-yl)-9H-purin-6-amine'>NO7</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | ||
+ | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4kbo|4kbo]], [[6nhk|6nhk]]</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6p2u FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6p2u OCA], [http://pdbe.org/6p2u PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6p2u RCSB], [http://www.ebi.ac.uk/pdbsum/6p2u PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6p2u ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/GRP75_HUMAN GRP75_HUMAN]] Implicated in the control of cell proliferation and cellular aging. May also act as a chaperone. | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Our early efforts to find a covalent inhibitor of mortalin, a member of the 70 kD heat shock protein (Hsp70) family, led us to solve the structure of the mortalin nucleotide-binding domain (NBD) in complex with N6-propargyladenosine-5'-diphosphate. The acquired structure emphasizes the ability of the nucleotide-binding pocket to accommodate modified ADP compounds. A library of ADP analogues modified at either the 2- or N6-positions of adenosine were screened against the mortalin-NBD. Competitive inhibition and binding assays of the analogues demonstrate that modifications at the 2- or N6-positions have potential to bind and inhibit mortalin uniquely compared to other Hsp70 homologs, and that modifications at the 2-position confer the greatest selectivity in binding and inhibition of the mortalin-NBD. This article is protected by copyright. All rights reserved. | ||
- | + | 2- and N6-Functionalized Adenosine-5'-diphosphate Analogues for the Inhibition of Mortalin.,Moseng MA, Nix JC, Page RC FEBS Lett. 2019 Jun 8. doi: 10.1002/1873-3468.13475. PMID:31177526<ref>PMID:31177526</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
- | [[Category: Moseng, M | + | <div class="pdbe-citations 6p2u" style="background-color:#fffaf0;"></div> |
- | [[Category: Page, R | + | == References == |
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Moseng, M A]] | ||
+ | [[Category: Page, R C]] | ||
+ | [[Category: Atpase]] | ||
+ | [[Category: Chaperone]] | ||
+ | [[Category: Complex]] | ||
+ | [[Category: Inhibitor]] |
Revision as of 06:13, 19 June 2019
Structure of Mortalin-NBD with N6-propargyladenosine-5'-diphosphate
|
Categories: Large Structures | Moseng, M A | Page, R C | Atpase | Chaperone | Complex | Inhibitor